Ram Info to acquire CCPS of Karkinos Healthcare; Stock jumps 5%

12 Jan 2022 , 09:49 AM

RAMINFO Limited has informed that Board of Directors in its meeting held on January 10, 2022 had resolved to subscribe to 50 units of Compulsory Convertible Preference Shares (CCPS) of KARKINOS HEALTHCARE PRIVATE LIMITED which are being offered at Face Value Rs10/- and premium of Rs2,24,990/- amounting to Rs2,25,000/- each.

RAMINFO intend collaborate closely with Karkinos to strengthen Healthcare vertical by leveraging Karkinos hybrid “hub and spoke” model, with owned specialized centers of clinical excellence and a distributed network of partners for last mile reach and delivery of care.

A robust technology backbone, with clinical decision support systems, ensures high quality service delivery that focuses on the patient’s well- being.

Karkinos Healthcare Private Ltd (KH), founded in July 2020, is technology driven, oncology focused, managed health care platform. Our mission is to ensure no person is deprived of quality care either by lack of access or affordability. KH has been founded by R Venkataramanan, former Managing Trustee of the Tata Trusts (ex-board member of Tata Memorial Hospital, Tata Medical Centre Trust; Tata Centres for cancer care).

A strong clinician team is led by Dr Moni Abraham K. (ex Director CCRC, Narayana Health, visiting professor Roswell Park Cancer Institute, NYU) and Dr. R. Sankaranarayanan (former Chief of Cancer Screening Group, Early Detection & Prevention Section and Special Advisor on Cancer Control at the International Agency for Research on Cancer, WHO).

Karkinos is backed by the Tata Group, Ratan Tata, Rakuten Medical Inc, a leading global biotech in oncology and several prominent institutions and individuals in India and abroad. Karkinos is proud to collaborate with Tata Memorial Hospital, UK’s Guys and St Thomas NHS Foundation Trust and has several research collaborations with leading academic institutions in the United States to ensure we are at the frontier of oncology treatment and care. The company also has several professionals of eminence in cancer care as part of its Global Scientific Advisory Board.

As per filing, the Turnover of KH is Rs0.36 lakhs as on March 31, 2021.

At around 9:48 AM, RAMINFO was trading at Rs154 per piece higher by 4.8% on Sensex.